zum Directory-modus

Krankheiten des Nervensystems

Literatur zum Parkinson-Syndrom


Alexi,, T.; Borlongan, C. V.; Faull, R. L.; Williams, C. E.; Clark, R. G.; Gluckman, P. D.; Hughes, P. E. (2000): Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. In: Prog. Neurobiol.. 60 , 409-470
Arle, J. E.; Alterman, R. L. (1999): Surgical options in Parkinson's disease. In: Med. Clin. North Am.. 83 , 483-498
Benazzouz, A.; Hallett, M. (2000): Mechanism of action of deep brain stimulation. In: Neurology. 55 , S13-S16
Bohn, M. C.; Kozlowski, D.; Connor, B. A. (2000): Glial cell line-derived neurotrophic factor (GDNF) as a defensive molecule for neurodegenerative disease: a tribute to the studies of antonia vernadakis on neuronal-glial interactions. In: Int. J. Dev. Neurosci.. 18 , 679-684
Borlongan , C. V. (2000): Transplantation therapy for Parkinson's disease. In: Expert. Opin. Investig. Drugs. 9 , 2319-2330
Brocks, D. R. (1999): Anticholinergic drugs used in Parkinson's disease: An overlooked class of drugs from a pharmacokinetic perspective. In: J. Pharm. Pharm. Sci.. 2 , 39-46
Brocks, D. R.; Forsyth, D.; Playfer , J. R.; Williams, A. C. (2000): The role of entacapone in the management of Parkinson's disease. In: Hosp. Med.. 61 , 267-271
Chase, T. N.; Oh, J. D.; Konitsiotis, S. (2000): Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms. In: J. Neurol.. 247 , II36-II42
Clarkson, E. D.; Freed, C. R. (1999): Development of fetal neural transplantation as a treatment for Parkinson's disease. In: Life Sci.. 65 , 2427-2437
Collier, T. J.; Sortwell, C. E. (1999): Therapeutic potential of nerve growth factors in Parkinson's disease. In: Drugs Aging. 14 , 261-287
Conley, S. C.; Kirchner, J. T. (1999): Medical and surgical treatment of Parkinson's disease. Strategies to slow symptom progression and improve quality of life. In: Postgrad. Med.. 106 , 41-44,49,52
Date, I.; Ohmoto, T. (1999): Neural transplantation for Parkinson's disease. In: Cell Mol. Neurobiol.. 19 , 67-78
Factor, S. A. (1999): Dopamine agonists. In: Med. Clin. North Am.. 83 , 415-vii
Fahn, S. (1998): Medical treatment of Parkinson's disease. In: J. Neurol.. 245 , 15-24
Follett, K. A. (2000): The surgical treatment of Parkinson's disease. In: Annu. Rev. Med.. 51 , 135-147
Freese, A. (1999): Restorative gene therapy approaches to Parkinson's disease. In: Med. Clin. North Am.. 83 , 537-548
Guay, D. R. (1999): Tolcapone, a selective catechol-O-methyltransferase inhibitor for treatment of Parkinson's disease. In: Pharmacotherapy. 19 , 6-20
Hornykiewicz, O. (1998): Biochemical aspects of Parkinson's disease. In: Neurology. 51 , S2-S9
Hubble, P. J. (1999): Novel drugs for Parkinson's disease. In: Med. Clin. North Am.. 83 , 525-536
Kupsch, A.; Earl, C. (1999): Neurosurgical interventions in the treatment of idiopathic Parkinson disease: neurostimulation and neural implantation. In: J. Mol. Med.. 77 , 178-184
Lesch, K. P. (1999): Gene transfer to the brain: emerging therapeutic strategy in psychiatry?. In: Biol. Psychiatry. 45 , 247-253
Lindvall, O. (2000): Neural transplantation in Parkinson's disease. In: Novartis Fund. Symp.. 231 , 110-123
Miller, G. W.; Gainetdinov, R. R.; Levey, A. I.; Caron, M. G. (1999): Dopamine transporters and neuronal injury. In: Trends Pharmacol. Sci.. 20 , 424-429
Murer, M. G.; Yan, Q.; Raisman-Vozari, R. (2001): Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. In: Prog. Neurobiol.. 63 , 71-124
Ozawa, K.; Fan, D. S.; Shen, Y.; Muramatsu, S.; Fujimoto, K.; Ikeguchi , K.; Ogawa, M.; Urabe, M.; Kume, A.; Nakano, I. (2000): Gene therapy of Parkinson's disease using adeno-associated virus (AAV) vectors. In: J. Neural Transm. Suppl. 231 , 181-191
Poewe, W.; Wenning, G. K. (2000): Apomorphine: an underutilized therapy for Parkinson's disease. In: Mov. Disord.. 15 , 789-794
Reichmann, H. (2000): Long-term treatment with dopamine agonists in idiopathic Parkinson's disease,. In: J. Neurol.. 247 , (13-14), IV/17-IV/19.
Ridet, J. L.; Deglon, N.; Aebischer, P. (2000): Gene transfer techniques for the delivery of GDNF in Parkinson's disease. In: Novartis Found. Symp.. 231 , 202-215
Schapira, A. H.; Obeso, J. A.; Olanow, C. W. (2000): The place of COMT inhibitors in the armamentarium of drugs for the treatment of Parkinson's disease. In: Neurology. 55 , S65-S68
Sealfon, S. C. (2000): Dopamine receptors and locomotor responses: molecular aspects. In: Ann. Neurol.. 47 , S12-S19
Sevcik, J.; Masek, K. (2000): Potential role of cannabinoids in Parkinson's disease. In: Drugs Aging. 16 , 391-395
Siegel, G. J.; Chauhan, N. B. (2000): Neurotrophic factors in Alzheimer's and Parkinson's disease brain. In: Brain Res. Brain Res. Rev.. 33 , 199-227

Zugang zur PubMed-Datenbank

Seite 7 von 9